RU2012114472A - METHOD FOR PRODUCING RECOMBINANT ENZYMATIC-LABELED HANTAVIRUS G2 ANTIGEN IN E.COLI CELLS FOR THE PURPOSE OF ITS APPLICATION IN AN IMMUNO-ENZYMAL ANALYSIS FOR DIAGNOSIS OF HFRS - Google Patents
METHOD FOR PRODUCING RECOMBINANT ENZYMATIC-LABELED HANTAVIRUS G2 ANTIGEN IN E.COLI CELLS FOR THE PURPOSE OF ITS APPLICATION IN AN IMMUNO-ENZYMAL ANALYSIS FOR DIAGNOSIS OF HFRS Download PDFInfo
- Publication number
- RU2012114472A RU2012114472A RU2012114472/10A RU2012114472A RU2012114472A RU 2012114472 A RU2012114472 A RU 2012114472A RU 2012114472/10 A RU2012114472/10 A RU 2012114472/10A RU 2012114472 A RU2012114472 A RU 2012114472A RU 2012114472 A RU2012114472 A RU 2012114472A
- Authority
- RU
- Russia
- Prior art keywords
- antigen
- hfrs
- diagnosis
- coli cells
- enzymal
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Способ получения рекомбинантного пептида НТ (производного поверхностного антигена G2 хантавируса Добрава) в клетках Е.coli, отличающегося наличием ферментативной метки в составе данного антигена, что позволяет повысить специфичность иммуноферментного анализа при диагностике ГЛПС.A method of producing a recombinant NT peptide (a derivative of the surface antigen G2 of the hantavirus Dobrava) in E. coli cells, characterized by the presence of an enzymatic label in the composition of this antigen, which allows to increase the specificity of the enzyme-linked immunosorbent assay for the diagnosis of HFRS.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012114472/10A RU2539836C2 (en) | 2012-04-12 | 2012-04-12 | METHOD OF OBTAINING RECOMBINANT ENZYME-LABELLED ANTIGEN G2 OF HANTAVIRUS IN E. coli CELLS AIMED AT ITS APPLICATION IN IMMUNOSORBENT ASSAY IN HFRS DIAGNOSTICS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012114472/10A RU2539836C2 (en) | 2012-04-12 | 2012-04-12 | METHOD OF OBTAINING RECOMBINANT ENZYME-LABELLED ANTIGEN G2 OF HANTAVIRUS IN E. coli CELLS AIMED AT ITS APPLICATION IN IMMUNOSORBENT ASSAY IN HFRS DIAGNOSTICS |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2012114472A true RU2012114472A (en) | 2013-10-20 |
RU2539836C2 RU2539836C2 (en) | 2015-01-27 |
Family
ID=49356956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012114472/10A RU2539836C2 (en) | 2012-04-12 | 2012-04-12 | METHOD OF OBTAINING RECOMBINANT ENZYME-LABELLED ANTIGEN G2 OF HANTAVIRUS IN E. coli CELLS AIMED AT ITS APPLICATION IN IMMUNOSORBENT ASSAY IN HFRS DIAGNOSTICS |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2539836C2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2180754C2 (en) * | 2000-04-10 | 2002-03-20 | Научно-исследовательский институт эпидемиологии и микробиологии СО РАМН | Method of chanta-virus diagnosticum preparing |
-
2012
- 2012-04-12 RU RU2012114472/10A patent/RU2539836C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2539836C2 (en) | 2015-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121862T1 (en) | ANTI-PHF-TAU ANTIBODIES AND USES THEREOF | |
CY1121208T1 (en) | NATALIZUMAB ANTIBODIES | |
TR201904997T4 (en) | Activity assays due to modification. | |
UY34333A (en) | ? METHODS AND COMPOSITIONS FOR WEED CONTROL, AND METHODS TO REDUCE THE EXPRESSION OF ENZYME DHPS? | |
CL2016000221A1 (en) | Afucosylated anti-fgfr2iiib antibodies. | |
UY32501A (en) | SPECIFIC ANTAGONIST ANTIBODY FOR ALFA4-BETA7 HETERODYMER | |
UY34343A (en) | PROTEINS OF UNION TO THE ANTIGEN CD27L | |
MA32712B1 (en) | ANTI-VEGF ANTI-ANG-2 BISPECIFIC ANTIBODY | |
BR112014026755A2 (en) | claudin 18.2 antibodies useful in cancer diagnosis | |
NZ606725A (en) | Methods for predicting anti-cancer response | |
UY34704A (en) | INDANILOXIDIHYDROBENZOFURANILACETIC ACIDS AS RECEPTOR AGONISTS 40 COUPLED TO PROTEIN G (GPR40) | |
UA111818C2 (en) | ANTIBODY AGAINST CSF-1R | |
BR112013020500A8 (en) | isolated, recombinant or purified antibody | |
BR112012023015A2 (en) | lenalidomide and thalidomide immunoassays | |
UY34317A (en) | T cell antireceptor antibody (alpha) / ß | |
UY34365A (en) | HETEROCICLICAL COMPOUNDS | |
DOP2013000296A (en) | THROMBOEMBOLIC DISEASE | |
BR112014001834A2 (en) | nematode biocontrol | |
UY34442A (en) | 2-THIOPIRIMIDINONES. | |
BR112014003501A2 (en) | antibodies that bind to alpha-v beta-8 integrin | |
EA201491959A1 (en) | AGONISTIC PEPTIDES FOR PAR4 | |
RU2011135537A (en) | Strain ENTEROCOCCUS HIRAE USED IN THE PRODUCTION OF Dairy Products | |
UY4153Q (en) | DRUMS | |
BR112015009301A2 (en) | nematode biocontrol | |
EA201300733A1 (en) | RECOMBINANT MICOBACTERIA AS A VACCINE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Correction of name of patent owner | ||
PD4A | Correction of name of patent owner | ||
PC43 | Official registration of the transfer of the exclusive right without contract for inventions |
Effective date: 20190301 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20190413 |